What are the administration instructions for ketorolac (Toradol) injection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ketorolac Injection Administration Instructions

Ketorolac tromethamine injection should be administered intramuscularly by injecting slowly and deeply into the muscle, or intravenously over no less than 15 seconds, with a maximum treatment duration of 5 days. 1

Dosing Guidelines

Intramuscular (IM) Administration

  • Patients <65 years of age:

    • Single-dose treatment: 60 mg
    • Multiple-dose treatment: 30 mg every 6 hours (maximum daily dose: 120 mg)
  • Patients ≥65 years, renally impaired, or <50 kg (110 lbs):

    • Single-dose treatment: 30 mg
    • Multiple-dose treatment: 15 mg every 6 hours (maximum daily dose: 60 mg)

Intravenous (IV) Administration

  • Patients <65 years of age:

    • Single-dose treatment: 30 mg
    • Multiple-dose treatment: 30 mg every 6 hours (maximum daily dose: 120 mg)
  • Patients ≥65 years, renally impaired, or <50 kg (110 lbs):

    • Single-dose treatment: 15 mg
    • Multiple-dose treatment: 15 mg every 6 hours (maximum daily dose: 60 mg)

Clinical Effects Timeline

  • Onset of action: ~30 minutes
  • Peak analgesic effect: 1-2 hours after administration
  • Duration of analgesic effect: 4-6 hours 1

Important Precautions

Contraindications

  • Active peptic ulcer disease
  • Recent gastrointestinal bleeding
  • Advanced renal impairment or risk of renal failure
  • History of hypersensitivity to aspirin or NSAIDs
  • Cerebrovascular bleeding
  • Hemorrhagic diathesis
  • Incomplete hemostasis
  • High risk of bleeding
  • Pregnancy 2, 1

Renal Considerations

  • Hypovolemia should be corrected prior to administration
  • Monitor blood pressure, BUN, creatinine, and liver function tests at baseline and periodically
  • Discontinue immediately if BUN or creatinine doubles or if hypertension develops/worsens 3, 1

Compatibility Information

Ketorolac should NOT be mixed in a small volume (e.g., in a syringe) with:

  • Morphine sulfate
  • Meperidine hydrochloride
  • Promethazine hydrochloride
  • Hydroxyzine hydrochloride

This will result in precipitation of ketorolac from solution 1.

Clinical Pearls

  1. Inspect solution visually for particulate matter and discoloration before administration
  2. For breakthrough pain, do not increase the dose or frequency of ketorolac
  3. Consider supplementing with low doses of opioids "prn" unless contraindicated
  4. Patients should be switched to alternative analgesics as soon as possible
  5. Ketorolac therapy should not exceed 5 days 1

Pediatric Considerations

For children, the recommended intravenous dosage is:

  • Initial dose: 0.5 mg/kg
  • Followed by either:
    • Bolus injections of 1.0 mg/kg every 6 hours, or
    • IV infusion of 0.17 mg/kg/h
  • Maximum daily dose: 90 mg
  • Maximum duration: 48 hours
  • Not recommended for infants <1 year of age 4

Remember that despite common practice of using higher doses, research suggests that ketorolac exhibits an analgesic ceiling effect, with 10 mg possibly being the ceiling dose 5. However, the FDA-approved dosing as outlined above should be followed for safe administration.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ketorolac Use in Patients with Renal Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Patterns of Ketorolac dosing by emergency physicians.

World journal of emergency medicine, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.